Symbotic Beats Q4 Revenue Forecast on Strong Operations Growth
Warehouse robotics leader Symbotic (SYM) exceeds Q4 revenue guidance with $618.5M in sales, driven by operations services growth. Company projects positive outlook for fiscal 2026.
Warehouse robotics leader Symbotic (SYM) exceeds Q4 revenue guidance with $618.5M in sales, driven by operations services growth. Company projects positive outlook for fiscal 2026.
Werewolf Therapeutics announces a 64% workforce reduction to save money, key executives leave with severance, and a new finance officer steps in as the company explores partnerships and funding options.
Disc Medicine's bitopertin gets turned down by FDA for treating EPP, a painful genetic condition making skin ultra-sensitive to sun.
ICE plans to spend $38.3 billion converting warehouses nationwide—including one near Hagerstown, MD—into large detention facilities for mass deportations. Companies like CoreCivic and GEO Group stand to benefit from the immigration detention boom.